This Genes and Disease page has been moved to:
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd.section.194

Please update your bookmarks.

If you are not automatically transported to the new page after 15 seconds, click on this link

.
Genes and disease header bar


newGenome View

SOD1
on chromosome 21
Databases

PubMed
the literature
LocusLink
collection of gene-related information
OMIM
catalog of human genes and disorders
Protein structure
the molecule in 3D
Information

The ALS Association
research and patient support
ALS Fact sheet
from the National Institute of Neurological Disorders and Stroke
MEDLINEplus
links on ALS compiled by the National Library of Medicine

AMYOTROPHIC LATERAL SCLEROSIS (ALS) is a neurological disorder characterized by progressive degeneration of motor neuron cells in the spinal cord and brain, which ultimately results in paralysis and death. The disease takes its less-scientific name from Lou Gehrig, a baseball player with the New York Yankees in the late 1920s and 1930s, who was forced to retire in 1939 as a result of the loss of motor control caused by the disease.
  In 1991, a team of researchers linked familial ALS to chromosome 21. Two years later, the SOD1 gene was identified as being associated with many cases of familial ALS. The enzyme coded for by SOD1 carries out a very important function in cells: it removes dangerous superoxide radicals by converting them into non-harmful substances. Defects in the action of this enzyme mean that the superoxide radicals attack cells from the inside, causing their death. Several different mutations in this enzyme all result in ALS, making the exact molecular cause of the disease difficult to ascertain.
  Recent research has suggested that treatment with drugs called anti-oxidants may benefit ALS patients. However, since the molecular genetics of the disease are still unclear, a significant amount of research is still required to design other promising treatments for ALS.